Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;36(8):695-708.
doi: 10.1037/neu0000851. Epub 2022 Aug 18.

Adaptation and construct validity evaluation of a tablet-based, short neuropsychological test battery for use with adolescents and young adults living with HIV in Thailand

Reuben N Robbins  1 , Anthony F Santoro  2 , Christopher Ferraris  2 , Nana Asiedu  2 , Jun Liu  1 , Curtis Dolezal  2 , Kathleen M Malee  3 , Claude A Mellins  1 , Robert Paul  4 , Kulvadee Thongpibul  5 , Thanyawee Puthanakit  6 , Linda Aurpibul  7
Affiliations

Adaptation and construct validity evaluation of a tablet-based, short neuropsychological test battery for use with adolescents and young adults living with HIV in Thailand

Reuben N Robbins et al. Neuropsychology. 2022 Nov.

Abstract

Objective: Deficits in neurocognitive functioning are common among adolescents and young adults (AYA) with perinatally acquired HIV (PHIV). Limitations of traditional neuropsychological tests hinder assessment of neurocognition in low- and middle-income countries where most AYA with PHIV reside. Computerized testing could make assessment of neurocognition more accessible in these countries. This study examined a culturally modified NeuroScreen, a tablet-based neurocognitive testing app, for use in Thailand. Construct validity was examined among Thai AYA (13-23 years) with and without PHIV.

Method: NeuroScreen underwent adaptation including language, content, and usability review by Thai psychologists, AYA, and clinical staff. One hundred Thai AYA (50 PHIV; 50 HIV-uninfected, matched controls) were administered the adapted NeuroScreen and a battery of traditional paper-and-pencil neuropsychological tests. Correlations, mean differences, and proportions with impaired performance were examined across NeuroScreen and the traditional tests.

Results: The Thai version of NeuroScreen was deemed understandable and culturally appropriate. A large correlation (.82) between overall performance on the NeuroScreen and traditional batteries was observed. Small-to-large correlations were found between conceptually similar NeuroScreen and traditional tests of processing speed, working memory, motor speed, and executive functioning. Mean test performance differences between AYA with PHIV and controls were similar between test batteries. Both sets of tests identified similar rates of impaired participants.

Conclusions: Results provide support for the acceptability and construct validity of the Thai NeuroScreen tests to assess neurocognition in Thai AYA with PHIV. An easy-to-use tool to assess neurocognition can help Thai providers provide better care for AYA with PHIV. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Adams W, & Sheslow D. (1990). WRAML manual. Jastak Associates.
    1. Aghvinian M, Santoro AF, Gouse H, Joska JA, Linda T, Thomas KGF, & Robbins RN (2021). Taking the test: A qualitative qnalysis of cultural and contextual factors impacting neuropsychological assessment of Xhosa-apeaking South Africans. Archives of Clinical Neuropsychology, 36(6), 976–980. 10.1093/arclin/acaa115 - DOI - PMC - PubMed
    1. American Educational Research Association. (2014). American Educational Research Association, American Psychological Association. Joint Committee: Standards for Educational and Psychological Testing.
    1. Antinori A, Arendt G, Grant I, Letendre S, Chair, Munoz-Moreno JA, Eggers C, Brew B, Brouillette M-J, Bernal-Cano F, Carvalhal A, Christo PP, Cinque P, Cysique L, Ellis R, Everall I, Gasnault J, Husstedt I, Korten V, … Drapato AW (2013). Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: A consensus report of the Mind Exchange Program. Clinical Infectious Diseases, 56(7), 1004–1017. 10.1093/cid/cis975 - DOI - PMC - PubMed
    1. Barber TJ, Bradshaw D, Hughes D, Leonidou L, Margetts A, Ratcliffe D, Thornton S, Pozniak A, Asboe D, Mandalia S, Boffito M, Davies N, Gazzard B, & Catalan J. (2014). Screening for HIV-related neurocognitive impairment in clinical practice: Challenges and opportunities. AIDS Care, 26(2), 160–168. 10.1080/09540121.2013.819401 - DOI - PubMed